Product
Vehicle Gel
Aliases
Placebo, Vehicle gel
7 clinical trials
6 indications
Indication
Seborrheic KeratosisIndication
Acne VulgarisIndication
Molluscum ContagiosumIndication
NeurofibromaIndication
Neurofibromatosis type 1Indication
Hand-Foot SyndromeClinical trial
Randomized Double-Blind Vehicle-Controlled Study of the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic KeratosisStatus: Active (not recruiting), Estimated PCD: 2024-06-15
Clinical trial
A Phase 3 Multi-Center, Randomized, Double-Blinded, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy, Tolerability and Safety of SB204 and Vehicle Gel Once Daily in the Treatment of Acne VulgarisStatus: Completed, Estimated PCD: 2016-12-01
Clinical trial
A Phase 3 Multi-Center, Randomized, Double-Blinded, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy, Tolerability and Safety of Once Daily SB204 and Vehicle Gel in the Treatment of Acne VulgarisStatus: Completed, Estimated PCD: 2016-12-01
Clinical trial
A Phase 3 Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy and Safety of SB206 and Vehicle Gel Once Daily in the Treatment of Molluscum ContagiosumStatus: Completed, Estimated PCD: 2021-04-28
Clinical trial
A Phase 2, Multi-Center, Randomized, Evaluator-Blinded, Vehicle-Controlled Study Comparing the Efficacy, Tolerability, and Safety of SB204 Gel and Vehicle Gel Once or Twice Daily in the Treatment of Acne VulgarisStatus: Completed, Estimated PCD: 2015-06-01
Clinical trial
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Phase 2 Dose-Response Study to Determine Safety and Effectiveness of Two Concentrations of NFX-179 Gel in Subjects With Cutaneous NeurofibromasStatus: Completed, Estimated PCD: 2023-10-04
Clinical trial
A Clinical Trial to Evaluate the Efficacy and Safety of Acetylated Natural Nucleotides in Treating Hand-foot Syndrome (HFS)Status: Completed, Estimated PCD: 2022-04-30